Live attenuated virus vaccine protects against SARS-CoV-2 variants of concern B.1.1.7 (Alpha) and B.1.351 (Beta).

Trimpert, JakobJakobTrimpertAdler, Julia MJulia MAdlerEschke, KathrinKathrinEschkeAbdelgawad, AzzaAzzaAbdelgawadFirsching, Theresa CTheresa CFirschingEbert, NadineNadineEbertTran, Thi Nhu ThaoThi Nhu ThaoTran0000-0003-3906-4629Gruber, Achim DAchim DGruberThiel, Volker EarlVolker EarlThielOsterrieder, NikolausNikolausOsterriederKunec, DusanDusanKunec2024-10-092024-10-092021-12-03https://boris-portal.unibe.ch/handle/20.500.12422/67547[Figure: see text].en600 - Technology::630 - Agriculture500 - Science500 - Science::570 - Life sciences; biology500 - Science::590 - Animals (Zoology)600 - Technology::610 - Medicine & healthLive attenuated virus vaccine protects against SARS-CoV-2 variants of concern B.1.1.7 (Alpha) and B.1.351 (Beta).article10.48350/1656483485167710.1126/sciadv.abk0172